Protein ultrastructure and the nanoscience of complement activation

Advanced Drug Delivery Reviews

Volumn 63, Issue 12, 2011, Pages 1008-1019

  Vorup Jensen, Thomas ^a   Boesen, Thomas ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Atomic force microscopy; Electron microscopy; Immunoglobulins; Immunology; Nanoparticles; Small angle scattering; X ray crystallography

Indexed keywords

COMPLEMENT SYSTEMS; CONFORMATIONAL CHANGE; HUMAN BODIES; IMMUNE RESPONSE; IMMUNOGLOBULINS; MICROBIAL CELLS; MOLECULAR CROWDING; NANO PARTICULATES; SMALL-ANGLE SCATTERING; SUPPORT FUNCTIONS; TISSUE DISTRIBUTIONS;

ATOMIC FORCE MICROSCOPY; IMMUNOLOGY; MINERALOGY; MOLECULAR BIOLOGY; NANOPARTICLES; NANOSCIENCE; PROTEINS; SELF ASSEMBLY; TISSUE;

X RAY CRYSTALLOGRAPHY;

COMPLEMENT; COMPLEMENT COMPONENT C2A; COMPLEMENT COMPONENT C2B; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN M; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; NANOMATERIAL; NANOPARTICLE;

ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; BIOENGINEERING; CELL WALL; COMPLEMENT ACTIVATION; ELECTRON MICROSCOPY; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MOLECULAR BIOLOGY; MOLECULAR SIZE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SMALL ANGLE SCATTERING; STRUCTURE ANALYSIS; SURFACE PROPERTY; TISSUE DISTRIBUTION; ULTRASTRUCTURE; X RAY CRYSTALLOGRAPHY;

ANIMALS; BIOCOMPATIBLE MATERIALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CRYSTALLOGRAPHY, X-RAY; HUMANS; NANOPARTICLES; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80052144227     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.05.023     Document Type: Review

References (129)

1. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
2. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
3. Gros P., Milder F.J., Janssen B.J. Complement driven by conformational changes. Nat. Rev. Immunol. 2008, 8:48-58.
4. Chen C.B., Wallis R. Stoichiometry of complexes between mannose-binding protein and its associated serine proteases. Defining functional units for complement activation. J. Biol. Chem. 2001, 276:25894-25902.
5. Vorup-Jensen T., Petersen S.V., Hansen A.G., Poulsen K., Schwaeble W., Sim R.B., Reid K.B., Davis S.J., Thiel S., Jensenius J.C. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J. Immunol. 2000, 165:2093-2100.
6. Takahashi M., Iwaki D., Kanno K., Ishida Y., Xiong J., Matsushita M., Endo Y., Miura S., Ishii N., Sugamura K., Fujita T. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J. Immunol. 2008, 180:6132-6138.
7. Selander B., Martensson U., Weintraub A., Holmstrom E., Matsushita M., Thiel S., Jensenius J.C., Truedsson L., Sjoholm A.G. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J. Clin. Invest. 2006, 116:1425-1434.
8. Matsushita M., Thiel S., Jensenius J.C., Terai I., Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 2000, 165:2637-2642.
9. Takahashi M., Ishida Y., Iwaki D., Kanno K., Suzuki T., Endo Y., Homma Y., Fujita T. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J. Exp. Med. 2010, 207:29-37.
10. Moller-Kristensen M., Thiel S., Sjoholm A., Matsushita M., Jensenius J.C. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int. Immunol. 2007, 19:141-149.
11. Kocsis A., Kekesi K.A., Szasz R., Vegh B.M., Balczer J., Dobo J., Zavodszky P., Gal P., Pal G. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation. J. Immunol. 2010, 185:4169-4178.
12. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2002, 2:346-353.
13. Thomsen T., Moeller J.B., Schlosser A., Sorensen G.L., Moestrup S.K., Palaniyar N., Wallis R., Mollenhauer J., Holmskov U. The recognition unit of FIBCD1 organizes into a noncovalently linked tetrameric structure and uses a hydrophobic funnel (S1) for acetyl group recognition. J. Biol. Chem. 2010, 285:1229-1238.
14. Krarup A., Thiel S., Hansen A., Fujita T., Jensenius J.C. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 2004, 279:47513-47519.
15. Frederiksen P.D., Thiel S., Larsen C.B., Jensenius J.C. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand. J. Immunol. 2005, 62:462-473.
16. Shimizu I., Kawahara T., Haspot F., Bardwell P.D., Carroll M.C., Sykes M. B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells. Blood 2007, 109:1773-1781.
17. Barrington R.A., Pozdnyakova O., Zafari M.R., Benjamin C.D., Carroll M.C. B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J. Exp. Med. 2002, 196:1189-1199.
18. Croix D.A., Ahearn J.M., Rosengard A.M., Han S., Kelsoe G., Ma M., Carroll M.C. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 1996, 183:1857-1864.
19. Szomolanyi-Tsuda E., Seedhom M.O., Carroll M.C., Garcea R.L. T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice. Virology 2006, 352:52-60.
20. Yalcindag A., He R., Laouini D., Alenius H., Carroll M., Oettgen H.C., Geha R.S. The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen. J. Allergy Clin. Immunol. 2006, 117:1455-1461.
21. Yaduguri V.T., Malhotra R. 'Plenty of room' - fifty years after the Feynman lecture. Curr. Sci. 2010, 99:900-907.
22. Kosaka N., McCann T.E., Mitsunaga M., Choyke P.L., Kobayashi H. Real-time optical imaging using quantum dot and related nanocrystals. Nanomedicine (Lond.) 2010, 5:765-776.
23. Follmann H., Brownson C. Darwin's warm little pond revisited: from molecules to the origin of life. Naturwissenschaften 2009, 96:1265-1292.
24. Sander B., Golas M.M. Visualization of bionanostructures using transmission electron microscopical techniques. Microsc. Res. Tech. 2011, 71:642-663.
25. Nagar B., Jones R.G., Diefenbach R.J., Isenman D.E., Rini J.M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 1998, 280:1277-1281.
26. Weis W.I., Drickamer K., Hendrickson W.A. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 1992, 360:127-134.
27. Weis W.I., Drickamer K. Trimeric structure of a C-type mannose-binding protein. Structure 1994, 2:1227-1240.
28. Sheriff S., Chang C.Y., Ezekowitz R.A. Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat. Struct. Biol. 1994, 1:789-794.
29. Schmidt C.Q., Herbert A.P., Mertens H.D., Guariento M., Soares D.C., Uhrin D., Rowe A.J., Svergun D.I., Barlow P.N. The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module. J. Mol. Biol. 2010, 395:105-122.
30. Milder F.J., Raaijmakers H.C., Vandeputte M.D., Schouten A., Huizinga E.G., Romijn R.A., Hemrika W., Roos A., Daha M.R., Gros P. Structure of complement component C2A: implications for convertase formation and substrate binding. Structure 2006, 14:1587-1597.
31. Janssen B.J., Huizinga E.G., Raaijmakers H.C., Roos A., Daha M.R., Nilsson-Ekdahl K., Nilsson B., Gros P. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 2005, 437:505-511.
32. Fredslund F., Jenner L., Husted L.B., Nyborg J., Andersen G.R., Sottrup-Jensen L. The structure of bovine complement component 3 reveals the basis for thioester function. J. Mol. Biol. 2006, 361:115-127.
33. Fredslund F., Laursen N.S., Roversi P., Jenner L., Oliveira C.L., Pedersen J.S., Nunn M.A., Lea S.M., Discipio R., Sottrup-Jensen L., Andersen G.R. Structure of and influence of a tick complement inhibitor on human complement component 5. Nat. Immunol. 2008, 9:753-760.
34. Janssen B.J., Christodoulidou A., McCarthy A., Lambris J.D., Gros P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 2006, 444:213-216.
35. Jing H., Babu Y.S., Moore D., Kilpatrick J.M., Liu X.Y., Volanakis J.E., Narayana S.V. Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J. Mol. Biol. 1998, 282:1061-1081.
36. Milder F.J., Gomes L., Schouten A., Janssen B.J., Huizinga E.G., Romijn R.A., Hemrika W., Roos A., Daha M.R., Gros P. Factor B structure provides insights into activation of the central protease of the complement system. Nat. Struct. Mol. Biol. 2007, 14:224-228.
37. Morgan H.P., Schmidt C.Q., Guariento M., Blaum B.S., Gillespie D., Herbert A.P., Kavanagh D., Mertens H.D., Svergun D.I., Johansson C.M., Uhrin D., Barlow P.N., Hannan J.P. Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 2011, 8:463-470.
38. Forneris F., Ricklin D., Wu J., Tzekou A., Wallace R.S., Lambris J.D., Gros P. Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science 2010, 330:1816-1820.
39. Feinstein A., Munn E.A. An electron microscopic study of the interaction of macroglobulin (IgM) antibodies with bacterial flagella and of the binding of complement. J. Physiol. 1966, 186:64P-66P.
40. Feinstein A., Munn E.A. Conformation of the free and antigen-bound IgM antibody molecules. Nature 1969, 224:1307-1309.
41. Roux K.H. Immunoglobulin structure and function as revealed by electron microscopy. Int. Arch. Allergy Immunol. 1999, 120:85-99.
42. Knobel H.R., Villiger W., Isliker H. Chemical analysis and electron microscopy studies of human C1q prepared by different methods. Eur. J. Immunol. 1975, 5:78-82.
43. Shelton E., Yonemasu K., Stroud R.M. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq). Proc. Natl. Acad. Sci. U.S.A. 1972, 69:65-68.
44. Reid K.B. Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement. Biochem. J. 1976, 155:5-17.
45. Reid K.B., Porter R.R. Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem. J. 1976, 155:19-23.
46. Brodsky-Doyle B., Leonard K.R., Reid K.B. Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem. J. 1976, 159:279-286.
47. Lu J.H., Thiel S., Wiedemann H., Timpl R., Reid K.B. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J. Immunol. 1990, 144:2287-2294.
48. Vorup-Jensen T., Jensenius J.C. Personal accounts of the discovery of MASP-2 and its role in the MBL pathway of complement activation. Molecular Aspects of Innate and Adaptive Immunity 2008, 129-146. RSCPublishing, London. K.B. Reid, R.B. Sim (Eds.).
49. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 2007, 44:3875-3888.
50. Dong M., Xu S., Oliveira C.L., Pedersen J.S., Thiel S., Besenbacher F., Vorup-Jensen T. Conformational changes in mannan-binding lectin bound to ligand surfaces. J. Immunol. 2007, 178:3016-3022.
51. DiScipio R.G., Hugli T.E. The architecture of complement component C9 and poly(C9). J. Biol. Chem. 1985, 260:14802-14809.
52. DiScipio R.G., Hugli T.E. The molecular architecture of human complement component C6. J. Biol. Chem. 1989, 264:16197-16206.
53. Deng Z.J., Mortimer G., Schiller T., Musumeci A., Martin D., Minchin R.F. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009, 20:455101.
54. Dobrovolskaia M.A., Patri A.K., Zheng J., Clogston J.D., Ayub N., Aggarwal P., Neun B.W., Hall J.B., McNeil S.E. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 2009, 5:106-117.
55. Ling W.L., Biro A., Bally I., Tacnet P., Deniaud A., Doris E., Frachet P., Schoehn G., Pebay-Peyroula E., Arlaud G.J. Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. ACS Nano 2011, 5:730-737.
56. Smith C.A., Vogel C.W., Muller-Eberhard H.J. MHC Class III products: an electron microscopic study of the C3 convertases of human complement. J. Exp. Med. 1984, 159:324-329.
57. Chamberlain D., Ullman C.G., Perkins S.J. Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modeling. Biochemistry 1998, 37:13918-13929.
58. Chen X., Xie C., Nishida N., Li Z., Walz T., Springer T.A. Requirement of open headpiece conformation for activation of leukocyte integrin alphaXbeta2. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14727-14732.
59. Nishida N., Xie C., Shimaoka M., Cheng Y., Walz T., Springer T.A. Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity 2006, 25:583-594.
60. Nishida N., Walz T., Springer T.A. Structural transitions of complement component C3 and its activation products. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19737-19742.
61. Torreira E., Tortajada A., Montes T., Rodriguez de Cordoba S., Llorca O. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:882-887.
62. Torreira E., Tortajada A., Montes T., Rodriguez de Cordoba S., Llorca O. Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase. J. Immunol. 2009, 183:7347-7351.
63. Mertens H.D., Svergun D.I. Structural characterization of proteins and complexes using small-angle X-ray solution scattering. J. Struct. Biol. 2010, 172:128-141.
64. Svergun D.I. Small-angle X-ray and neutron scattering as a tool for structural systems biology. Biol. Chem. 2010, 391:737-743.
65. Perkins S.J. X-ray and neutron scattering analyses of hydration shells: a molecular interpretation based on sequence predictions and modelling fits. Biophys. Chem. 2001, 93:129-139.
66. Perkins S.J., Villiers C.L., Arlaud G.J., Boyd J., Burton D.R., Colomb M.G., Dwek R.A. Neutron scattering studies of subcomponent C1q of first component C1 of human complement and its association with subunit C1r2C1s2 within C1. J. Mol. Biol. 1984, 179:547-557.
67. Perkins S.J., Smith K.F., Nealis A.S., Lachmann P.J., Harrison R.A. Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering. Biochemistry 1990, 29:175-180.
68. Smith K.F., Harrison R.A., Perkins S.J. Molecular modeling of the domain structure of C9 of human complement by neutron and X-ray solution scattering. Biochemistry 1992, 31:754-764.
69. Smith K.F., Nolan K.F., Reid K.B., Perkins S.J. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat. Biochemistry 1991, 30:8000-8008.
70. Sun Z., Reid K.B., Perkins S.J. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling. J. Mol. Biol. 2004, 343:1327-1343.
71. Perkins S.J., Nealis A.S., Sim R.B. Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. Biochemistry 1991, 30:2847-2857.
72. Hinshelwood J., Spencer D.I., Edwards Y.J., Perkins S.J. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B. J. Mol. Biol. 1999, 294:587-599.
73. Aslam M., Perkins S.J. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J. Mol. Biol. 2001, 309:1117-1138.
74. Perkins S.J., Smith K.F., Sim R.B. Molecular modelling of the domain structure of factor I of human complement by X-ray and neutron solution scattering. Biochem. J. 1993, 295(Pt 1):101-108.
75. Boyd J., Burton D.R., Perkins S.J., Villiers C.L., Dwek R.A., Arlaud G.J. Neutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solution. Proc. Natl. Acad. Sci. U. S.A. 1983, 80:3769-3773.
76. Zaccai G., Aude C.A., Thielens N.M., Arlaud G.J. Neutron scattering study of the (gamma-B) catalytic domains of complement proteases activated C1r and C1s. FEBS Lett. 1990, 269:19-22.
77. Perkins S.J., Nealis A.S., Sutton B.J., Feinstein A. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling. A possible mechanism for complement activation. J. Mol. Biol. 1991, 221:1345-1366.
78. Czajkowsky D.M., Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14960-14965.
79. Quesenberry M.S., Drickamer K. Determination of the minimum carbohydrate-recognition domain in two C-type animal lectins. Glycobiology 1991, 1:615-621.
80. Bernado P., Mylonas E., Petoukhov M.V., Blackledge M., Svergun D.I. Structural characterization of flexible proteins using small-angle X-ray scattering. J. Am. Chem. Soc. 2007, 129:5656-5664.
81. Bernado P. Effect of interdomain dynamics on the structure determination of modular proteins by small-angle scattering. Eur. Biophys. J. 2010, 39:769-780.
82. Oliveira C.L.P., Vorup-Jensen T., Andersen C.B.F., Andersen G.R., Pedersen J.S. Discovering new features of protein complexes structures by small-angle X-ray scattering. Applications of Synchrotron Light to Scattering and Diffraction in Materials and Life Sciences 2009, 231-244. Springer Verlag, Heidelberg. T.A. Ezquerra, M.C. Garcia-Gomez, M. Gomez (Eds.).
83. Svergun D.I., Barberato C., Koch M.H.J. CRYSOL - a program to evalate X-ray solution scattering of biological m acromolecules from atomic coordinates. J. Appl. Crystallogr. 1995, 28:768-773.
84. Perkins S.J., Okemefuna A.I., Nan R., Li K., Bonner A. Constrained solution scattering modelling of human antibodies and complement proteins reveals novel biological insights. J. R. Soc. Interface 2009, 6(Suppl 5):S679-S696.
85. Janssen B.J., Gomes L., Koning R.I., Svergun D.I., Koster A.J., Fritzinger D.C., Vogel C.W., Gros P. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex. EMBO J. 2009, 28:2469-2478.
86. Jensenius H., Klein D.C., van Hecke M., Oosterkamp T.H., Schmidt T., Jensenius J.C. Mannan-binding lectin: structure, oligomerization, and flexibility studied by atomic force microscopy. J. Mol. Biol. 2009, 391:246-259.
87. Michelow I.C., Dong M., Mungall B.A., Yantosca L.M., Lear C., Ji X., Karpel M., Rootes C.L., Brudner M., Houen G., Eisen D.P., Kinane T.B., Takahashi K., Stahl G.L., Olinger G.G., Spear G.T., Ezekowitz R.A., Schmidt E.V. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J. Biol. Chem. 2010, 285:24729-24739.
88. Walivaara B., Askendal A., Lundstrom I.I., Tengvall P. Imaging of the early events of classical complement activation using antibodies and atomic force microscopy. J. Colloid Interface Sci. 1997, 187:121-127.
89. Linderstrøm-Lang K.U. Proteins and enzymes. Lane Medical Lectures 1952, Stanford University Press.
90. Nonaka M., Kimura A. Genomic view of the evolution of the complement system. Immunogenetics 2006, 58:701-713.
91. Lo Conte L., Chothia C., Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 1999, 285:2177-2198.
92. Schroeder A., Levins C.G., Cortez C., Langer R., Anderson D.G. Lipid-based nanotherapeutics for siRNA delivery. J. Intern. Med. 2010, 267:9-21.
93. Debbage P. Targeted drugs and nanomedicine: present and future. Curr. Pharm. Des. 2009, 15:153-172.
94. Murphy K., Travers P., Walport M.J. Janeway's Immunobiology 2008, Garland Science, New York.
95. Capon S.M., Goldfinger D. Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 1995, 35:513-520.
96. Pineda A.A., Vamvakas E.C., Gorden L.D., Winters J.L., Moore S.B. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999, 39:1097-1103.
97. Yazdanbakhsh K. Controlling the complement system for prevention of red cell destruction. Curr. Opin. Hematol. 2005, 12:117-122.
98. Greenwood D., Slack R., Peutherer J., Barer M. Medical Microbiology 2007, Churchill Livingstone Elsevier, Edinburgh. 7th ed.
99. Pangburn M.K., Schreiber R.D., Muller-Eberhard H.J. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J. Immunol. 1983, 131:1930-1935.
100. Pedersen M.B., Zhou X., Larsen E.K., Sorensen U.S., Kjems J., Nygaard J.V., Nyengaard J.R., Meyer R.L., Boesen T., Vorup-Jensen T. Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation. J. Immunol. 2010, 184:1931-1945.
101. Karmali P.P., Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin. Drug Deliv. 2011, 8:343-357.
102. Davis G.E. The Mac-1 and p150,95 beta 2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp. Cell Res. 1992, 200:242-252.
103. Vorup-Jensen T., Carman C.V., Shimaoka M., Schuck P., Svitel J., Springer T.A. Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1614-1619.
104. Stapulionis R., Oliveira C.L., Gjelstrup M.C., Pedersen J.S., Hokland M.E., Hoffmann S.V., Poulsen K., Jacobsen C., Vorup-Jensen T. Structural insight into the function of myelin basic protein as a ligand for integrin alpha M beta 2. J. Immunol. 2008, 180:3946-3956.
105. Brevig T., Holst B., Ademovic Z., Rozlosnik N., Rohrmann J.H., Larsen N.B., Hansen O.C., Kingshott P. The recognition of adsorbed and denatured proteins of different topographies by beta2 integrins and effects on leukocyte adhesion and activation. Biomaterials 2005, 26:3039-3053.
106. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L., Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 2006, 43:193-201.
107. Salvador-Morales C., Basiuk E.V., Basiuk V.A., Green M.L., Sim R.B. Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. J. Nanosci. Nanotechnol. 2008, 8:2347-2356.
108. Teillet F., Dublet B., Andrieu J.P., Gaboriaud C., Arlaud G.J., Thielens N.M. The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases. J. Immunol. 2005, 174:2870-2877.
109. Li Y., Karlin A., Loike J.D., Silverstein S.C. Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J. Exp. Med. 2004, 200:613-622.
110. Borsos T., Rapp H.J. Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J. Immunol. 1965, 95:559-566.
111. Bally I., Rossi V., Lunardi T., Thielens N.M., Gaboriaud C., Arlaud G.J. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. J. Biol. Chem. 2009, 284:19340-19348.
112. Brier S., Pflieger D., Le Mignon M., Bally I., Gaboriaud C., Arlaud G.J., Daniel R. Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex. J. Biol. Chem. 2010, 285:32251-32263.
113. Phillips A.E., Toth J., Dodds A.W., Girija U.V., Furze C.M., Pala E., Sim R.B., Reid K.B., Schwaeble W.J., Schmid R., Keeble A.H., Wallis R. Analogous interactions in initiating complexes of the classical and lectin pathways of complement. J. Immunol. 2009, 182:7708-7717.
114. Beller D.I., Springer T.A., Schreiber R.D. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 1982, 156:1000-1009.
115. Micklem K.J., Sim R.B. Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem. J. 1985, 231:233-236.
116. Wilkinson B.J., Kim Y., Peterson P.K. Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid. Infect. Immun. 1981, 32:216-224.
117. Touhami A., Jericho M.H., Beveridge T.J. Atomic force microscopy of cell growth and division in Staphylococcus aureus. J. Bacteriol. 2004, 186:3286-3295.
118. Law S.K.A., Reid K.B. Complement 1995, IRL Press, Oxford. 2nd ed.
119. Degn S.E., Thiel S., Jensenius J.C. New perspectives on mannan-binding lectin-mediated complement activation. Immunobiology 2007, 212:301-311.
120. Francius G., Domenech O., Mingeot-Leclercq M.P., Dufrene Y.F. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin. J. Bacteriol. 2008, 190:7904-7909.
121. Lovelace L.L., Cooper C.L., Sodetz J.M., Lebioda L. Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement. J. Biol. Chem. 2011, 286:17585-17592.
122. DiScipio R.G., Chakravarti D.N., Muller-Eberhard H.J., Fey G.H. The structure of human complement component C7 and the C5b-7 complex. J. Biol. Chem. 1988, 263:549-560.
123. Jing H., Macon K.J., Moore D., DeLucas L.J., Volanakis J.E., Narayana S.V. Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. EMBO J. 1999, 18:804-814.
124. DiScipio R.G. Ultrastructures and interactions of complement factors H and I. J. Immunol. 1992, 149:2592-2599.
125. Smith C.A., Pangburn M.K., Vogel C.W., Muller-Eberhard H.J. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J. Biol. Chem. 1984, 259:4582-4588.
126. Harris L.J., Larson S.B., Hasel K.W., McPherson A. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 1997, 36:1581-1597.
127. Gregory L., Davis K.G., Sheth B., Boyd J., Jefferis R., Nave C., Burton D.R. The solution conformations of the subclasses of human IgG deduced from sedimentation and small angle X-ray scattering studies. Mol. Immunol. 1987, 24:821-829.
128. Roux K.H., Tankersley D.L. A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG. J. Immunol. 1990, 144:1387-1395.
129. Thomson N.H. The substructure of immunoglobulin G resolved to 25kDa using amplitude modulation AFM in air. Ultramicroscopy 2005, 105:103-110.